MetLife (MET) Stock Price, News & Analysis

Company Overview

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was incorporated in 1999 and is based in New York, New York.

Key Stats

• Today's Range: $79.48 to $82.32
• 50-Day Range: $78.15 to $88.25
• 52-Week Range: $64.61 to $89.05
• Volume: 8.23 million shs
• Average Volume: 3.22 million shs
• Market Capitalization: $56.34 billion
• P/E Ratio: 16.40
• Dividend Yield: 2.68%
• Price Target: $88.62
• Consensus Rating: Buy

MetLife Stock Analysis - MarketRank™

MetLife scored higher than 98% of companies evaluated by MarketBeat, and ranked 20th out of 935 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.5 / 5
• Analyst Rating: Buy

Consensus Rating

MetLife has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 13 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

MetLife has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 4.4 / 5
• Proj. Earnings Growth: 16.75%

Earnings Growth

Earnings for MetLife are expected to grow by 16.75% in the coming year, from $8.30 to $9.69 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of MetLife is 16.40, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 113.39.

Price to Earnings Ratio vs. Sector

The P/E ratio of MetLife is 16.40, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 26.63.

Price to Earnings Growth Ratio

MetLife has a PEG Ratio of 0.74. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

MetLife has a P/B Ratio of 1.99. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.07% of the float of MetLife has been sold short.

Short Interest Ratio / Days to Cover

MetLife has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in MetLife has recently increased by 24.00%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 4.2 / 5
• Dividend Strength: Strong

Dividend Yield

MetLife pays a meaningful dividend of 2.72%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

MetLife has been increasing its dividend for 11 years.

Dividend Coverage

The dividend payout ratio of MetLife is 43.95%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, MetLife will have a dividend payout ratio of 22.50% next year. This indicates that MetLife will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 3.0 / 5
• Environmental Score: -0.75

Percentage of Shares Shorted

1.07% of the float of MetLife has been sold short.

Short Interest Ratio / Days to Cover

MetLife has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in MetLife has recently increased by 24.00%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 1.8 / 5
• News Sentiment: 0.32

News Sentiment

MetLife has a news sentiment score of 0.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.75 average news sentiment score of Finance companies.

News Coverage This Week

MarketBeat has tracked 13 news articles for MetLife this week, compared to 19 articles on an average week.

Search Interest

30 people have searched for MET on MarketBeat in the last 30 days. This is an increase of 67% compared to the previous 30 days.

MarketBeat Follows

Only 8 people have added MetLife to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, MetLife insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.31% of the stock of MetLife is held by insiders.

Percentage Held by Institutions

94.99% of the stock of MetLife is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

MET Stock Analysis - Frequently Asked Questions

How have MET shares performed this year?

MetLife's stock was trading at $66.13 at the beginning of 2024. Since then, MET stock has increased by 23.0% and is now trading at $81.36.
View the best growth stocks for 2024 here.

How were MetLife's earnings last quarter?

MetLife, Inc. (NYSE:MET) released its quarterly earnings results on Wednesday, July, 31st. The financial services provider reported $2.28 EPS for the quarter, beating the consensus estimate of $2.13 by $0.15. The firm's revenue for the quarter was up 7.2% compared to the same quarter last year.
Read the conference call transcript.

Is MetLife doing a stock buyback?

MetLife's Board of Directors authorized a stock buyback plan on Wednesday, May 1st 2024, which allows the company to repurchase $3,000,000,000 in shares, according to EventVestor. This means that the company could reacquire up to 6% of its stock through open market purchases. Stock buyback plans are often a sign that the company's board believes its shares are undervalued.

Does MetLife have any subsidiaries?

MetLife subsidiaries include Versant Health, Willing, Logan Circle Partners, American Life Insurance Company, Safeguard Health Enterprises, Grand Bank N.A., General American Life Insurance Company, and others.

Who are MetLife's major shareholders?

Top institutional shareholders of MetLife include State Street Corp (3.86%), Wellington Management Group LLP (2.68%), Geode Capital Management LLC (1.70%) and Pzena Investment Management LLC (1.39%). Insiders that own company stock include Steven J Goulart, Ramy Tadros, Marlene Debel, Bill Pappas, Susan M Podlogar and Jeh C Johnson.
View institutional ownership trends.

How do I buy shares of MetLife?

Shares of MET stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of MetLife own?

Based on aggregate information from My MarketBeat watchlists, some other companies that MetLife investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Exxon Mobil (XOM), Salesforce (CRM) and Verizon Communications (VZ).

Company Calendar

• Last Earnings: 7/31/2024
• Ex-Dividend for 12/16 Dividend: 11/05/2024
• Dividend Payable: 12/16/2024
• Today: 12/21/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Finance
• Industry: Life insurance
• Sub-Industry: Life & Health Insurance
• Current Symbol: NYSE:MET
• CUSIP: 59156R10
• CIK: 1099219
• Web: www.metlife.com
• Phone: (212) 578-9500
• Fax: 212-578-3320
• Employees: 45,000
• Year Founded: 1868

Price Target and Rating

• Average Stock Price Target: $88.62
• High Stock Price Target: $99.00
• Low Stock Price Target: $80.00
• Potential Upside/Downside: +8.9%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 13 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $4.96
• Trailing P/E Ratio: 16.40
• Forward P/E Ratio: 9.80
• P/E Growth: 0.74
• Net Income: $1.58 billion
• Net Margins: 5.27%
• Pretax Margin: 7.26%
• Return on Equity: 20.01%
• Return on Assets: 0.86%

Debt

• Debt-to-Equity Ratio: 0.51
• Current Ratio: 0.16
• Quick Ratio: 0.16

Sales & Book Value

• Annual Sales: $70.55 billion
• Price / Sales: 0.80
• Cash Flow: $6.80 per share
• Price / Cash Flow: 11.96
• Book Value: $40.87 per share
• Price / Book: 1.99

Miscellaneous

• Outstanding Shares: 692,420,000
• Free Float: 690,273,000
• Market Cap: $56.34 billion
• Optionable: Optionable
• Beta: 1.06